Functional Diagnostics in New York

Endure Industries is a medical device manufacturing and distribution company based in Homer, New York, specializing in single-use surgical items with a primary focus on anesthesia delivery systems and airway management devices. The company serves hospitals, surgery centers, EMS providers, nursing homes, and the U.S. Department of Defense. Their product portfolio encompasses anesthesia breathing circuits, endotracheal tubes, oxygen delivery devices (including Venturi masks and BVM resuscitators), ETCO2 cannulas, cautery blades, wound care supplies, medical tapes, gauze, syringes, needles, and medical gloves. Endure is FDA-compliant and women-owned, emphasizing transparent procurement practices with competitive pricing. The company operates 24/7 customer support and offers free shipping on orders over $75.

Aktina Medical Corp. is a radiation oncology equipment and services company specializing in stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), and precision localization and immobilization solutions for LINAC (linear accelerator) treatments. The company manufactures and distributes patient immobilization systems, respiratory compression devices, cone collimators for small-field radiation delivery, and quality assurance systems for radiation therapy equipment. Primary product lines include the positionPRO modular immobilization system (offering pitch and roll correction for cranial, cervical spine, and head/neck treatments), SBRT systems, Elekta small-field circular cones, respiratory compression belts, and the isoPoint machine vision platform for LINAC isocenter optimization and calibration. Aktina also provides medical physics consultation services, diagnostic and therapeutic physics support, and quality assurance solutions including the SpiroCheck Duo system for active breathing control (ABC) validation. The company serves radiation oncology departments, cancer centers, and tertiary care hospitals requiring high-precision patient positioning and LINAC calibration for intracranial, head/neck, and body-based radiation treatments. Products are designed for compatibility with Elekta LINAC platforms and emphasize both treatment precision and patient comfort through innovative immobilization technology.

Companion Spine is a spine care technology company focused on interventional therapies and minimally invasive solutions for degenerative disc disease, spinal stenosis, injury-related pain, and general back pain. The company develops and provides diagnostic technologies, pain management interventions, minimally invasive surgical tools, and implantable devices designed to preserve motion, respect natural anatomy, and avoid unnecessary permanent interventions. Their product portfolio includes recent acquisitions such as Coflex® and other devices from Xtant™. All Companion Spine technologies and therapies are designed for outpatient delivery in comfortable, discreet settings, emphasizing proactive, ongoing spine care that minimizes disruption to patient quality of life. The company positions itself as a provider of reversible, motion-preserving treatments delivered through percutaneous or minimally invasive surgical procedures, with a clinical approach that prioritizes early detection and conservative treatment before advanced surgical intervention becomes necessary.

Soteria Medical B.V. is a specialized medical device manufacturer focused on MRI-guided in-bore prostate biopsy solutions. The company has developed a proprietary Remote Controlled Manipulator (RCM)—a fully MRI-compatible robotic device for precision prostate interventions. The RCM enables real-time, near real-time targeting of suspicious prostate lesions within the MRI bore, significantly improving diagnostic accuracy for prostate cancer detection and reducing the need for multiple unnecessary biopsy cores. The RCM system addresses key clinical challenges: it delivers high diagnostic accuracy (reported 70% prostate cancer detection rates), reduces procedure duration (typically under 30 minutes), minimizes patient discomfort by eliminating general anesthesia, and improves specimen quality for pathological analysis. The device features intuitive planning software and remote needle-guide positioning, enabling radiologists to perform precise, guided biopsies with minimal patient motion and reduced in-bore time. Soteria Medical's technology has been validated by leading radiologists across multiple institutions in Europe (Spain, Italy, Netherlands, France, Norway), with testimonials emphasizing clinical safety, diagnostic efficiency, and positive patient experience compared to transrectal ultrasound (TRUS) guidance. The company's offering is positioned for hospital radiology departments and diagnostic imaging centers specializing in urologic oncology and prostate cancer diagnosis. Recent market recognition includes CMS introduction of dedicated CPT codes (55713, 55714) for in-bore MR-guided prostate biopsy, reflecting clinical differentiation and reimbursement support in the US market. Soteria Medical is an active participant in major medical imaging conferences (ECR).

Oculogica Inc. is a woman-owned medical device company specializing in non-invasive eye-tracking diagnostic technology for objective concussion assessment. The flagship product, EyeBOX®, is FDA-cleared to aid in concussion diagnosis by measuring ocular motor abnormalities caused by cranial nerve impairment. The test is completed in under four minutes and delivers an objective "BOX score" within ten seconds, eliminating the need for baseline testing. Clinically validated through 16 peer-reviewed studies, EyeBOX® provides objective neurological assessment across patient ages 5–67 and is reimbursable. The technology serves sports medicine, veteran care, accident clinics, therapeutic clinics, and eye clinics. Oculogica's proprietary algorithms ensure diagnostic consistency across healthcare settings and improve communication between patients, families, and providers.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company specializing in non-invasive drug screening and monitoring solutions. The company develops rapid, dignified testing systems that detect drug use through sweat analysis, eliminating the need for invasive collection methods. The flagship Intelligent Fingerprinting Drug Testing Solution analyzes fingertip sweat to detect commonly abused drugs including cannabis, cocaine, opiates, and methamphetamine, with sample collection completed in under one minute and results delivered in under ten minutes. The system detects drug use within a 16–24 hour window prior to testing. The company also offers the SmarTest Patch, a wearable, tamper-evident, water-resistant transdermal patch that continuously monitors drug use over 7–10 days, suitable for justice system and rehabilitation applications. Both products employ sweat-based bioanalysis rather than traditional urine or blood screening. Intelligent Bio Solutions submitted an FDA 510(k) application in December 2024, with US market entry planned for 2025. The company is targeting multiple industries and the rapidly expanding drug screening market, including roadside testing applications. Current development includes a rapid drug screening cartridge targeting sub-3-minute results. The technology represents a shift toward non-invasive, accessible, and dignified drug testing approaches suitable for workplace screening, law enforcement, criminal justice, substance abuse treatment programs, and rehabilitation facilities.

Gemstar Inc. is a US-based wholesale distributor of medical supplies, surgical products, pharmaceuticals, and medical devices. The company operates as a full-service medical supply wholesaler with a substantial inventory of globally-recognized branded products sourced from reputable suppliers. Their product portfolio encompasses medical consumables, diagnostic tools, personal protective equipment, pharmaceutical supplies, surgical instruments, sutures, surgical drapes and gowns, sterilization supplies, and dental supplies. The company also distributes health and wellness products including skincare, oral care, and health supplements, as well as sanitation supplies including cleaning agents, soaps, wipes, and sanitizers. Gemstar holds wholesale distribution licenses across the United States, enabling operations in pharmaceutical, medical device, and related product distribution. The company maintains ISO 9001 certification, demonstrating commitment to quality management systems, and is compliant with NCDQS (National Coalition for Drug Quality & Security) regulations and OSHA workplace safety standards. Their operations prioritize rigorous quality control measures including regular audits and adherence to industry standards. The company serves healthcare facilities, clinics, and related institutional customers through B2B wholesale channels. Gemstar also operates under the business name Medexco Supply Corp.

Fluidda NV is a global leader in Functional Respiratory Imaging (FRI), a proprietary technology that combines high-resolution CT (HRCT) scans with Computational Fluid Dynamics (CFD) and artificial intelligence to advance respiratory healthcare. The company operates as both a Contract Research Organization (CRO) and a clinical decision-support partner, serving pharmaceutical, biotech, and healthcare organizations in drug development, medical device validation, and patient diagnosis and monitoring. Fluidda's FRI technology enables detailed regional lung functionality assessment, personalized treatment optimization, and accelerated clinical trial design for respiratory conditions including asthma, COPD, cystic fibrosis, and other pulmonary diseases. The platform provides clinicians and researchers with visualization and quantitative analysis of airflow patterns and regional lung physiology beyond standard spirometry, supporting precision medicine approaches. Fluidda recently joined Banook, a global clinical trial services organization, enhancing its capacity to deliver end-to-end respiratory drug and device development solutions. The company serves healthcare systems, pulmonologists, radiologists, and respiratory researchers worldwide, with demonstrated applications in real-world clinical practice and public health initiatives. Fluidda's technology reduces clinical trial timelines, improves cost-effectiveness, and supports evidence-based treatment selection for better patient outcomes in respiratory disease management.

Allergy & Applicator Depot supplies FDA-compliant allergy diagnostic and immunotherapy products for medical practices. The company specializes in turnkey allergy testing kits, diagnostic antigen extracts, skin test applicators, and immunotherapy treatments (SLIT/SCIT). Product lines include environmental, food, and pediatric diagnostic test kits in various panel sizes (24–80 allergens), corresponding antigen extract sets for skin testing, and multi-prong applicators (8-prong and 10-prong configurations) available in bulk quantities (200–600 count cases). The company markets its offerings as cost-effective, CLIA-free solutions designed to help practices identify patient allergen triggers, generate diagnostic revenue, and offer long-term immunotherapy treatment options. Regulatory compliance includes FDA approval and CLIA exemption status. Target market comprises allergists, primary care practices, and other medical providers seeking to add allergy testing and treatment services.

Proven Medical Testing LLC is an FDA-registered distributor of rapid diagnostic tests and sterile surgical kits for clinical practices, urgent care centers, and physician offices. Founded by New York clinicians, the company sources point-of-care diagnostics and single-use surgical supplies directly from FDA-registered manufacturers and distributes them at transparent wholesale pricing. Product portfolio includes rapid antigen tests for influenza A & B, RSV, Strep A, and hCG pregnancy testing; sterile removal kits for staples and sutures; and IV start kits. All SKUs are FDA-registered and traceable. The company operates from a New York warehouse with same-day dispatch capability for in-stock orders placed before 2 PM ET, Monday–Friday. Free domestic shipping and international fulfillment available. Volume-tier pricing and bulk quotes offered to high-volume reorder accounts.

Healthy.io Ltd. develops smartphone-based clinical diagnostic solutions using computer vision, colorimetric analysis, and AI algorithms to enable remote patient testing from home. The company's core offering transforms a patient's smartphone camera into a clinical-grade medical device capable of analyzing urine tests for early detection of kidney disease and chronic wound assessment. The platform is FDA-cleared and CE-marked, featuring seamless EMR integration via SMART on FHIR standards. Products include Minuteful Kidney for home-based kidney function testing and Minuteful Wound for wound care assessment. The company partners with health systems, health plans (including Medica and Blue Cross of Idaho), and wound care providers to improve screening completion rates, advance health equity, and close the care loop with post-test services. The technology operates across varying devices and lighting conditions, achieving 93% patient satisfaction and up to 50% completion rates among previously untested populations. Healthy.io targets at-risk patient populations, rural communities, and healthcare systems seeking to address the gap where 90% of individuals with chronic kidney disease remain undiagnosed.

Chembio Diagnostics, Inc. is a leading developer and manufacturer of rapid point-of-care (POC) diagnostic tests for infectious diseases, headquartered in Hauppauge, New York, with operations in Medford, New York. The company specializes in innovative diagnostic solutions utilizing its proprietary Dual Path Platform (DPP®) technology, which delivers improved sensitivity, multiplexing capabilities, and rapid results from a small sample of fingertip blood. Chembio's product portfolio includes FDA-approved and CLIA-waived assays for HIV, syphilis, Hepatitis C, COVID-19, and emerging infectious disease detection. The company also develops quantitative diagnostics (FastPack® hCG) and is actively advancing diagnostics for typhoid fever and preeclampsia. With 337 employees and approximately $55.3 million in annual revenue, Chembio markets its solutions to medical laboratories, hospitals, government health agencies, NGOs, and retail establishments across the United States and internationally. The company is committed to delivering exceptional, easy-to-use, fast, and accurate diagnostic solutions to enhance health outcomes in infectious disease detection and monitoring.

Polymedco is a B2B medical diagnostics company specializing in early detection and screening solutions for life-threatening diseases. The company develops and markets two primary product lines: OC-Auto® FIT, an automated fecal immunochemical test for colorectal cancer screening, and PATHFAST® Cardiac Biomarker Analyzer, a point-of-care (POC) cardiac testing platform. OC-Auto FIT is marketed as the number-one automated noninvasive CRC screening tool globally, carrying a Tier 1 US Preventive Services Task Force guideline recommendation, and has demonstrated clinical evidence of improving patient compliance (43.8% increase), reducing annual CRC incidence (25.5% reduction), and reducing cancer mortality (52.4% reduction). The PATHFAST analyzer performs lab-quality cardiac biomarker testing from a single whole blood sample, delivering results in minutes with measurements of Troponin I, NTproBNP, D-Dimer, hsCRP, CK-MB, and Myoglobin. Both systems are designed for integration into healthcare systems, reference laboratories, and point-of-care settings. Polymedco emphasizes customer-centric support, offering customizable programmatic solutions, technical implementation support, and LIS (Laboratory Information System) integration. The company partners with healthcare systems, payors, providers, and reference laboratories to improve screening accessibility and affordability. Products feature robust clinical evidence and user-friendly design for high-volume, cost-effective screening and diagnostic workflows.